Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M69.9Revenue (TTM) $M24.3Net Margin (%)-131.7Altman Z-Score-8.4
Enterprise Value $M149EPS (TTM) $-0.7Operating Margin %-151.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.5Pre-tax Margin (%)-131.4Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %1.5Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-40.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-106.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.1ROIC % (ttm)-158.6Gross Margin Increase y-yY

Gurus Latest Trades with ALIM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ALIM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ALIM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAVP, L.P.10% Owner 2016-04-21Sell478,673$2.59-40.15view
EISWIRTH RICHARD S JRCOO and CFO 2015-12-16Sell46,669$2.31-32.9view
Flynn James E 2015-12-08Buy272,249$3.01-48.5view
Flynn James E 2015-12-03Buy243,252$3-48.33view
Flynn James E 2015-11-06Buy73,250$2.98-47.99view
Flynn James E 2015-10-30Buy16,542$3-48.33view
Flynn James E 2015-10-28Buy59,342$3-48.33view
Flynn James E 2015-10-26Buy60,364$3-48.33view
Flynn James E 2015-10-21Buy390,040$2.97-47.81view
EISWIRTH RICHARD S JRCOO and CFO 2015-10-15Sell13,625$2.69-42.38view

Quarterly/Annual Reports about ALIM:

    News about ALIM:

    Articles On GuruFocus.com
    Alimera Sciences Inc. (ALIM) President and CEO C. Daniel Myers sells 45,523 Shares Mar 16 2011 
    The Most Speculative Stocks on the Market: Harbinger, Kaching Kaching, Alimera Sciences, Star Scient Jul 29 2010 

    More From Other Websites
    ALIMERA SCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... May 27 2016
    Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision... May 23 2016
    Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision... May 23 2016
    ETF’s with exposure to Alimera Sciences, Inc. : May 19, 2016 May 19 2016
    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q1, 2016 By the Numbers May 18 2016
    ALIMERA SCIENCES INC Financials May 17 2016
    Alimera Sciences to Present at the UBS Global Healthcare Conference May 17 2016
    Alimera Sciences to Present at the UBS Global Healthcare Conference May 17 2016
    Alimera Sciences' ILUVIEN® Data Presented at SFO 2016 May 11 2016
    Edited Transcript of ALIM earnings conference call or presentation 5-May-16 2:00pm GMT May 06 2016
    ALIMERA SCIENCES INC Files SEC form 10-Q, Quarterly Report May 06 2016
    Alimera Sciences' ILUVIEN® Data Presented At 2016 ARVO May 06 2016
    Alimera Sciences' ILUVIEN® Data Presented At 2016 ARVO May 06 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition May 05 2016
    Alimera Sciences reports 1Q loss May 04 2016
    Alimera Sciences reports 1Q loss May 04 2016
    Alimera Sciences Announces First Quarter 2016 Financial Results May 04 2016
    Alimera Sciences Announces First Quarter 2016 Financial Results May 04 2016
    Q1 2016 Alimera Sciences Inc Earnings Release - After Market Close May 04 2016
    Stonegate Capital Partners Initiates Coverage on Alimera Sciences Apr 27 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)